Esophageal candidiasis secondary prevention

Jump to navigation Jump to search

Esophageal candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal candidiasis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal candidiasis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal candidiasis secondary prevention

CDC on Esophageal candidiasis secondary prevention

Esophageal candidiasis secondary prevention in the news

Blogs on Esophageal candidiasis secondary prevention

Directions to Hospitals Treating Esophageal candidiasis

Risk calculators and risk factors for Esophageal candidiasis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy.

Secondary prevention

  • Secondary prevention strategies following esophageal candidiasis in HIV patients include prophylactic fluconazole therapy in a dose of 100-200 mg repeated 3 times/week.[1]
  • It has been proven to decrease recurrence of esophageal candidiasis.

References

  1. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016). "Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America". Clin. Infect. Dis. 62 (4): e1–50. doi:10.1093/cid/civ933. PMC 4725385. PMID 26679628.